H49.819 Kearns-Sayre syndrome, unspecified eye

Name of the Condition

• Kearns-Sayre syndrome, unspecified eye

Summary

Kearns-Sayre syndrome is a rare mitochondrial disorder characterized by progressive external ophthalmoplegia (weakness of the eye muscles), pigmentary retinopathy, and cardiac conduction defects. This specific code applies to manifestations affecting an unspecified eye. The condition typically presents before age 20 and may involve systemic manifestations such as ataxia, hearing loss, or endocrine abnormalities. It is caused by deletions in mitochondrial DNA and follows a progressive course.

Causes

Kearns-Sayre syndrome is caused by large deletions in mitochondrial DNA, which disrupt energy production in cells. These deletions are usually sporadic and not inherited from parents. The exact trigger for these deletions is not fully understood, but they result in impaired mitochondrial function affecting multiple organ systems, including the ocular structures.

Risk Factors

• Age of onset (typically before 20 years)
• Sporadic mitochondrial DNA deletions
• Family history of mitochondrial disorders (rare)

Symptoms

• Progressive external ophthalmoplegia (eye muscle weakness) affecting an unspecified eye
• Pigmentary retinopathy (retinal changes) in an unspecified eye
• Cardiac conduction defects (e.g., heart block)
• Ataxia (loss of coordination)
• Hearing loss
• Endocrine abnormalities (e.g., diabetes, thyroid issues)
• Short stature
• Cognitive impairment (in some cases)

Diagnosis

Diagnosis is based on clinical features (ophthalmoplegia, retinopathy, cardiac conduction defects) and confirmed by genetic testing for mitochondrial DNA deletions. Additional tests may include electrocardiography (ECG) to assess cardiac function, brain imaging, and endocrine evaluations to identify systemic involvement.

Treatment Options

Treatment focuses on managing symptoms and complications. This may include cardiac pacing for conduction defects, physical therapy for ataxia, hearing aids for hearing loss, and hormone replacement for endocrine abnormalities. Regular monitoring of cardiac and ocular health is essential.

Prognosis and Follow-Up

The prognosis varies, with most patients experiencing progressive symptoms over time. Regular follow-up with a multidisciplinary team (ophthalmologist, cardiologist, neurologist) is recommended to address systemic manifestations and prevent complications. Lifespan may be reduced due to cardiac or respiratory issues.

Complications

• Complete heart block or other cardiac arrhythmias
• Respiratory failure
• Severe vision loss
• Endocrine dysfunction (e.g., diabetes, thyroid disorders)
• Neurological deterioration

Lifestyle & Prevention

While Kearns-Sayre syndrome cannot be prevented, managing symptoms through regular medical care and avoiding triggers (e.g., certain medications) may improve quality of life. Genetic counseling is advised for families, though most cases are sporadic.

When to Seek Professional Help

Seek immediate medical attention for symptoms like sudden vision changes, chest pain, fainting, or difficulty breathing, which may indicate cardiac or respiratory complications. Regular check-ups are recommended for ongoing management of systemic symptoms.

Tips for Medical Coders

Use this code for Kearns-Sayre syndrome when the eye involvement is unspecified. Document the clinical context, including whether the condition affects one or both eyes, to support accurate coding. Ensure alignment with ICD-10-CM guidelines for mitochondrial disorders and ocular manifestations.